Analytical validation of the PROphet computational model for clinical benefit prediction and decision-making tool in metastatic NSCLC https://www.biorxiv.org/content/10.1101/2023.04.20.537648v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.